travoprost · Glaukos · NDA 218010
Idose Tr
Earliest generic entry, as listed
14 Feb 2031
Blocked by patent: US 12201555.
Listed patents · 4 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 12201555 | substance, product | 14 Feb 2031 |
| US 10206813 | product | 17 Oct 2030 |
| US 11426306 | product | 17 Oct 2030 |
| US 12201557 | substance, product, use U-4129 | 18 Jun 2030 |
Exclusivities · 1 unexpired
| NP | new product | 13 Dec 2026 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- 24 Oct 2026Exclusivity expires within 90 days NP · 218010-00113 Dec 2026
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 218010 · 001 · RLD | implant, intracameral | 75MCG | 14 Feb 2031 |